Vir Biotechnology (VIR) Shares Outstanding (Weighted Average) (2018 - 2026)

Vir Biotechnology's Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $147.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 7.19% year-over-year to $147.4 million; the TTM figure through Mar 2026 stood at $147.4 million (up 7.19% YoY), while the FY2025 annual figure was $138.5 million, up 1.67% from the prior year.
• Shares Outstanding (Weighted Average) came in at $147.4 million for Q1 2026 at Vir Biotechnology, up from $138.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $147.4 million in Q1 2026 to a low of $132.1 million in Q1 2022.
• A 5-year average of $135.8 million and a median of $135.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) grew 0.93% in 2023 and advanced 7.19% in 2026, its largest moves.
• Vir Biotechnology's Shares Outstanding (Weighted Average) stood at $132.6 million in 2022, then grew by 1.15% to $134.1 million in 2023, then grew by 1.58% to $136.2 million in 2024, then advanced by 1.67% to $138.5 million in 2025, then gained by 6.38% to $147.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $147.4 million, $138.5 million, and $138.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison